Roche's 2020 Losses to Biosimilars Were "Worst It Can Get"

Retrieved on: 2021-02-09 14:26:15

Tags for this article:

Click the tags to see associated articles and topics

Roche's 2020 Losses to Biosimilars Were "Worst It Can Get". View article details on hiswai:

Excerpt

Biosimilar competition took a big chunk of revenue from Roche's aging blockbusters in 2020, and the company is banking on its newer medicines to ...

Article found on: www.centerforbiosimilars.com